There is no scientific evidence that Viacreme can enhance sexual pleasure in women.
Viacreme is a topical cream that contains menthol and L-arginine. It is being promoted to increase sexual response in women by sensitizing the genital area. Many cancer patients may have painful intercourse and difficulty in maintaining arousal resulting from stress, hormonal changes, cancer treatments, or use of antidepressants. The manufacturer claims application of Viacreme in the clitoral region results in genital warming and increased clitoral sensitivity. The L-arginine increases blood flow to the genital tissue. However, this claim is not supported by clinical studies and the positive results of Viacreme may be due to a placebo effect. This product has not been studied in cancer patients.
Viacreme is a topical formulation of menthol and L-arginine in an aqueous base. It is promoted to enhance sexual responsiveness in women by sensitizing the genital area. Cancer patients may experience symptoms of sexual dysfunction that include painful intercourse, loss of libido, and difficulty in maintaining arousal. These problems may be caused by factors such as stress, hormonal changes, and treatment involving surgery, radiation, chemotherapy, or hormone therapy. Application of Viacreme is believed to cause genital warming and increase clitoral sensitivity, although these results may be due to placebo effects.
No clinical trials have been conducted to study the efficacy of Viacreme. Use of Viacreme may cause a sensation of strong genital burning.
This product has not been studied in cancer patients.
Menthol (0.25 - 0.5%) in Viacreme is thought to facilitate absorption of L-arginine and cause increase in vaginal lubrication. L-arginine is converted to nitric oxide by nitric oxide synthase that may result in vasodilation of the genital tissues.